Paris
France
27
2022-09-08
24
2024-11-05
These are the the leading inventors for applications assigned to BIOPROJET:
BIOPROJET based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands
#2 | 2022-03-17 ✅ Patent 12,059,416 granted on 2024-08-13Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof
#3 | 2020-01-30 ✅ Patent 11,229,632 granted on 2022-01-25Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof
#4 | 2020-01-23 ✅ Patent 11,078,183 granted on 2021-08-03Tetrahydrate of H3 ligand, its process of preparation and pharmaceutical compositions comprising the same
#5 | 2019-05-16 ✅ Patent 11,306,069 granted on 2022-04-19Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands
#6 | 2019-04-25 ✅ Patent 10,952,987 granted on 2021-03-23Combination of adrenalin with an antidepressant for use in the treatment of shocks
#7 | 2015-01-01 ✅ Patent 9,029,357 granted on 2015-05-12Benzazole derivatives as histamine H4 receptor ligands
#8 | 2014-04-10 ✅ Patent 9,266,867 granted on 2016-02-23Piperidinyl monocarboxylic acids as S1P1 receptor agonists
#9 | 2013-12-12 ✅ Patent 9,439,853 granted on 2016-09-13Form of administration of enkephalinase inhibitor
#10 | 2013-12-05 ✅ Patent 9,242,959 granted on 2016-01-26(Aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications
#11 | 2013-12-05 ✅ Patent 9,255,101 granted on 2016-02-096,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands
#12 | 2013-09-05 ✅ Patent 8,802,664 granted on 2014-08-12Benzazole derivatives as histamine H4 receptor ligands
#13 | 2012-11-15 ✅ Patent 8,354,430 granted on 2013-01-15Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine
#14 | 2012-05-24NOVEL PHARMACEUTICALLY ACCEPTABLE SALTS OF 4-(1H-IMIDAZOL-4-YLMETHYL)PYRIDINE AND THEIR THERAPEUTICAL USES
#15 | 2010-09-30 ✅ Patent 8,809,539 granted on 2014-08-19Dicarboxylic acid derivatives as S1P1 receptor agonists
#16 | 2009-12-24 ✅ Patent 8,486,947 granted on 2013-07-16Treatment of Parkinson's disease, obstructive sleep apnea, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H-receptor ligands
#17 | 2009-12-17COMBINATION OF MODAFINIL AND AN ANTAGONIST OR INVERSE AGONIST OF THE H3 RECEPTOR
#18 | 2009-11-19 ✅ Patent 8,802,678 granted on 2014-08-12Carbonylated (aza) cyclohexanes as dopamine Dreceptor ligands
#19 | 2009-07-23 ✅ Patent 8,318,203 granted on 2012-11-27Form of administration of racecadotril
#20 | 2009-04-30 ✅ Patent 8,076,329 granted on 2011-12-13Histamine H3-receptor ligands and their therapeutic applications
#21 | 2008-09-11 ✅ Patent 8,207,197 granted on 2012-06-26Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine
#22 | 2008-09-04Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands
#23 | 2008-07-31 ✅ Patent 8,017,646 granted on 2011-09-13Histamine H-receptor ligands and their therapeutic application
#24 | 2006-09-21 ✅ Patent 8,106,041 granted on 2012-01-31Combination product comprising an antagonist or inverse agonist of histamine receptor H and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs
#25 | 2006-04-27 ✅ Patent 7,432,269 granted on 2008-10-07Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents
#26 | 2005-07-19 ✅ Patent 6,919,093 granted on 2005-07-19Formulation
#27 | 2005-04-12 ✅ Patent 6,878,723 granted on 2005-04-12LTA4 hydrolase inhibitors
Also check out BIOPROJET's (Paris, France) applicant profile with 9 patent applications submitted.
37842 ⎘